ATE274920T1 - Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen - Google Patents

Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen

Info

Publication number
ATE274920T1
ATE274920T1 AT98956450T AT98956450T ATE274920T1 AT E274920 T1 ATE274920 T1 AT E274920T1 AT 98956450 T AT98956450 T AT 98956450T AT 98956450 T AT98956450 T AT 98956450T AT E274920 T1 ATE274920 T1 AT E274920T1
Authority
AT
Austria
Prior art keywords
antibodies
transplant rejection
antibody
administration
alone
Prior art date
Application number
AT98956450T
Other languages
English (en)
Inventor
Terry Strom
Xian Chang Li
Martin S Zand
Xin Xiao Zheng
Original Assignee
Wyeth Corp
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp, Beth Israel Hospital filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE274920T1 publication Critical patent/ATE274920T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AT98956450T 1997-10-31 1998-10-30 Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen ATE274920T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6385397P 1997-10-31 1997-10-31
PCT/US1998/023264 WO1999022766A2 (en) 1997-10-31 1998-10-30 Use of anti-il-12 antibodies in transplantation rejection

Publications (1)

Publication Number Publication Date
ATE274920T1 true ATE274920T1 (de) 2004-09-15

Family

ID=22051951

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98956450T ATE274920T1 (de) 1997-10-31 1998-10-30 Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen

Country Status (6)

Country Link
EP (1) EP0969867B1 (de)
AT (1) ATE274920T1 (de)
AU (1) AU744302B2 (de)
CA (1) CA2276420A1 (de)
DE (1) DE69825976T2 (de)
WO (1) WO1999022766A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7883704B2 (en) 1999-03-25 2011-02-08 Abbott Gmbh & Co. Kg Methods for inhibiting the activity of the P40 subunit of human IL-12
US6914128B1 (en) 1999-03-25 2005-07-05 Abbott Gmbh & Co. Kg Human antibodies that bind human IL-12 and methods for producing
NZ578065A (en) 2007-01-16 2012-09-28 Abbott Lab Methods for treating psoriasis with an antibody which binds to an epitope
NZ598881A (en) 2007-03-29 2013-11-29 Abbvie Inc Crystalline anti-human il-12 antibodies
EP2650311A3 (de) 2007-11-27 2014-06-04 Ablynx N.V. Gegen heterodimere Cytokine und/oder deren Rezeptoren gerichtete Aminosäuresequenzen und Polypeptide damit
NZ587765A (en) 2008-03-18 2013-02-22 Abbott Lab Methods for treating psoriasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL336464A1 (en) * 1997-03-18 2000-06-19 Basf Ag Method of and compositions for modulating reactivity in respect to corticosteroids i

Also Published As

Publication number Publication date
CA2276420A1 (en) 1999-05-14
WO1999022766A2 (en) 1999-05-14
EP0969867B1 (de) 2004-09-01
AU744302B2 (en) 2002-02-21
WO1999022766A3 (en) 1999-08-05
EP0969867A2 (de) 2000-01-12
AU1297499A (en) 1999-05-24
DE69825976T2 (de) 2005-09-01
DE69825976D1 (de) 2004-10-07

Similar Documents

Publication Publication Date Title
TR199902818T2 (xx) Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler.
BR9707049A (pt) Agentes anticoagulantes utilizáveis no tratamento de trombose
ES2160116T3 (es) Modelo de equivalente de cornea producido in vitro.
DE60334364D1 (de) Behandlungsverfahren unter verwendung von anti-cd22-antikörpern
DK0507933T3 (da) Nær-vaskulariserende implantationsmateriale
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
EP0975672A4 (de) Antikörper zur inhibierung der blutgerinnung und verfahren zur deren verwendung
NZ527076A (en) Graft rejection inhibitors used in combination with immunosuppressants
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
DE60026691D1 (de) Staphylococcus-antigene und impstoff
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DK69890D0 (da) Monoklonale antistoffer, der er reaktive med cachetin
IL143596A0 (en) Vascular endothelial cell growth factor antagonists and uses thereof
IT8867010A0 (it) Protesi valvolare cardiaca
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
HK1042052A1 (zh) 內皮血管生長因子-2
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ATE427488T1 (de) Monoklonaler antikírper fur die inhibierung von hiv-1-hullgykoprotein-vermittelte membranfusion
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
ATE274920T1 (de) Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen
FR2749022B1 (fr) Cellules aviaires immortelles
DE69120287T2 (de) Aminosulfonylharnstoff-acat-inhibitoren
DK0840620T3 (da) IL-8-antagonister til behandling af astma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0969867

Country of ref document: EP

REN Ceased due to non-payment of the annual fee